Genomics BioSci & Tech. Co.,Ltd. (TPE:4195)
Taiwan · Delayed Price · Currency is TWD 13.60
-0.60 (-4.23%)
At close: Sep 11, 2026
Genomics BioSci & Tech. Market Cap
Genomics BioSci & Tech. has a market cap or net worth of 1.09 billion as of September 11, 2026. Its market cap has decreased by -39.93% in one year.
Market Cap
1.09B
Enterprise Value
1.53B
Revenue
718.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.60
ChartMarket Cap Chart
Since December 16, 2013, Genomics BioSci & Tech.'s market cap has decreased from 1.58B to 1.09B, a decrease of -31.19%. That is a compound annual growth rate of -2.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 1.09B | -41.57% |
| Dec 31, 2025 | 1.86B | 33.85% |
| Dec 31, 2024 | 1.39B | -7.69% |
| Dec 29, 2023 | 1.51B | 19.84% |
| Dec 30, 2022 | 1.26B | 11.67% |
| Dec 30, 2021 | 1.13B | 0.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 19.66B |
| Elixiron Immunotherapeutics (Cayman) Limited | 19.54B |
| Intelligene | 8.21B |
| Uwell Biopharma | 7.20B |
| Obigen Pharma | 5.26B |
| Tripartite Therapeutics | 4.91B |
| Pet Pharm Biotech | 3.35B |
| BIONET Therapeutics | 2.42B |